Notwithstanding, TIA treatment did not demonstrate efficacy in decreasing the elevated expression of Hif1a. Additionally, an increase in the expression of various metalloproteinases in neuroinflammation and stroke has been reported in previous studies [80]. The gene discussed is HIF1A; the disease is transient ischemic attack.